There are currently no known outstanding effects for the The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 7.
7. In regulation 23 (insertion of regulation 57 (functions in relation to good clinical practice)), in the inserted regulation 57—U.K.
(a)in paragraph (1), after “Regulations may” insert “ , in respect of Great Britain ”;
(b)for paragraphs (2) and (3) substitute—
“(2) Any power to make regulations under paragraph (1)—
(a)is exercisable by the Secretary of State by statutory instrument;
(b)includes power to make—
(i)different provision for different purposes or different areas;
(ii)consequential, supplementary, incidental, transitional, transitory or saving provisions, including consequential amendments to these Regulations.
(3) Regulations under paragraph (1) are subject to annulment in pursuance of a resolution of either House of Parliament.”.
Commencement Information
I1Sch. 1 para. 7 in force at 31.12.2020 immediately before IP completion day, see reg. 1
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
